Emergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day
August 31, 2020 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it is teaming up with the Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and...
Emergent BioSolutions Receives NIH Research Grant to Further Develop AP007, Its Development Stage Sustained-Release Nalmefene Treatment for Opioid Use Disorder
September 27, 2019 06:35 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a research grant awarded by the National Institute on Drug Abuse (NIDA), a component of...
OPIOIDS AND HOMELESSNESS: STUDY IDENTIFIES STRATEGIES FOR COMBATTING BOTH
July 24, 2019 10:26 ET
|
Abt Associates
Rockville, Md., July 24, 2019 (GLOBE NEWSWIRE) -- Housing is vital to well-being, which makes addressing the link between opioid use disorder (OUD) and homelessness all the more important. To...
N.M. Cannabis Patient Enrollment on Track to Exceed 80,000 by Year End
June 07, 2019 14:24 ET
|
Ultra Health
ALBUQUERQUE, N.M., June 07, 2019 (GLOBE NEWSWIRE) -- The New Mexico Department of Health (NMDOH) added six new qualifying conditions for medical cannabis on Thursday, effectively raising the total...
Sen-Jam Pharmaceutical Underscores the Urgent Need to Revolutionize Pain Management and End the Opioid Epidemic at the 2019 StartUp Health Festival
February 13, 2019 08:00 ET
|
Sen-Jam Pharmaceutical
HUNTINGTON, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Sen-Jam Pharmaceutical, a therapeutic company focused on bringing relief to the opioid crisis, was delighted to present at the 2019 StartUp Health...
BioCorRx Awarded NIDA Grant of Approximately $5.7 Million for BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder
January 22, 2019 07:30 ET
|
BioCorRx Inc
ANAHEIM, CA, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
Sen-Jam Pharmaceutical Reports the Positive Effect of Payer Options and Expanded Coverage for Individuals with Opioid Use Disorder
August 30, 2018 14:53 ET
|
Sen-Jam Pharmaceutical
HUNTINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Opioid Epidemic is an incredibly complex and multifaceted problem facing America. We wanted to investigate the developments in medications,...
NanoMedical Systems Receives $3M Grant to Advance nStrada™ Implantable Nanofluidics System for Long-Term Treatment of Opioid Use Disorder
August 14, 2018 08:00 ET
|
NanoMedical Systems, Inc.
AUSTIN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- NanoMedical Systems, Inc. (NMS), an Austin-based company developing implantable, sustained-release, drug-delivery devices based on its nStrada™...